2001: A prospective, seasonal odyssey into antiphospholipid protein antibodies

Tissue plasminogen activator for acute ischemic stroke in patients with unruptured cerebral aneurysms.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2013

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

Oncogene·2011

Moyamoya syndrome associated with Sneddon's syndrome and antiphospholipid-protein antibodies.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2007

Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.

Oncogene·2007

The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial.

Neurology·2007

Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID.

Neurology·2006

Early Life Vascular Risk and Midlife Markers of Brain Aging.

Stroke·2026

Transcarotid Artery Revascularization Versus Carotid Artery Stenting for Asymptomatic Carotid Stenosis.

Stroke·2026

Sodium-Glucose Cotransporter 2 Inhibitor Use and Functional Outcomes After Endovascular Thrombectomy in Diabetic Stroke.

Stroke·2026

Circulating Metabolites Are Biomarker Candidates for Stroke Risk Prediction: Results From the BiomarCaRE Project.

Stroke·2026

High-Resolution Disconnectome Predicts Outcome and Response to Thrombectomy in Basilar Artery Occlusion.

Stroke·2026

Vessel Wall MRI in Pediatric Arterial Ischemic Stroke: Diagnostic Utility and Prognostic Value.

Stroke·2026

Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.

Journal of cutaneous medicine and surgery·2026

Management of thyroid disorders: from autoimmunity to malignancy - novel insights from precision medicine: How to manage thyroid diseases: from autoimmunity to malignancy Special Issue.

Drugs in context·2026

Gut microbiome dysbiosis is associated with aldosterone overproduction in idiopathic hyperaldosteronism.

iScience·2026

Physicochemically-guided immunomodulatory biomaterials for regulating immune responses in rheumatoid arthritis.

Materials today. Bio·2026

SAVI: molecular mechanisms, clinical spectrum and precision medicine approaches beyond type-I IFN.

Frontiers in immunology·2026

How to manage autoimmune hyperthyroidism (Graves' disease): from differential diagnosis to emerging immunological therapies.

Drugs in context·2026

Related Experiment Videos

2001: A prospective, seasonal odyssey into antiphospholipid protein antibodies

Related Concept Videos

Tissue plasminogen activator for acute ischemic stroke in patients with unruptured cerebral aneurysms.

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

Moyamoya syndrome associated with Sneddon's syndrome and antiphospholipid-protein antibodies.

Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.

The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial.

Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID.

Early Life Vascular Risk and Midlife Markers of Brain Aging.

Transcarotid Artery Revascularization Versus Carotid Artery Stenting for Asymptomatic Carotid Stenosis.

Sodium-Glucose Cotransporter 2 Inhibitor Use and Functional Outcomes After Endovascular Thrombectomy in Diabetic Stroke.

Circulating Metabolites Are Biomarker Candidates for Stroke Risk Prediction: Results From the BiomarCaRE Project.

High-Resolution Disconnectome Predicts Outcome and Response to Thrombectomy in Basilar Artery Occlusion.

Vessel Wall MRI in Pediatric Arterial Ischemic Stroke: Diagnostic Utility and Prognostic Value.

Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.

Management of thyroid disorders: from autoimmunity to malignancy - novel insights from precision medicine: How to manage thyroid diseases: from autoimmunity to malignancy Special Issue.

Gut microbiome dysbiosis is associated with aldosterone overproduction in idiopathic hyperaldosteronism.

Physicochemically-guided immunomodulatory biomaterials for regulating immune responses in rheumatoid arthritis.

SAVI: molecular mechanisms, clinical spectrum and precision medicine approaches beyond type-I IFN.

How to manage autoimmune hyperthyroidism (Graves' disease): from differential diagnosis to emerging immunological therapies.

Related Experiment Videos

2001: A prospective, seasonal odyssey into antiphospholipid protein antibodies

Related Concept Videos

Related Articles